Copyright: ©Author(s) 2026.
World J Virol. Mar 25, 2026; 15(1): 118602
Published online Mar 25, 2026. doi: 10.5501/wjv.v15.i1.118602
Published online Mar 25, 2026. doi: 10.5501/wjv.v15.i1.118602
Table 1 Distribution of beta-lactamase producing Klebsiella isolates among various clinical specimens, n (%)
| Specimen | ESBL producers (n = 77) | AmpC producers (n = 62) |
| Pus (n = 55) | 35 (63.63) | 27 (49) |
| Blood (n = 10) | 6 (60) | 2 (20) |
| Catheter tip (n = 1) | 1 (100) | 1 (100) |
| Body fluid (n = 21) | 12 (57.1) | 8 (38) |
| Endotracheal aspirate (n = 4) | 3 (75) | 4 (100) |
| Sputum (n = 12) | 6 (50) | 3 (25) |
| Urine (n = 27) | 14 (51.8) | 17 (62.96) |
| Total = 130 | 59.2% | 47.7% |
- Citation: Kaur H, Arora S, Sharma V, Kaur K, Kamboj S. Study of extended-spectrum beta-lactamases and AmpC beta-lactamases producing Klebsiella from clinical samples in tertiary care hospital of Punjab. World J Virol 2026; 15(1): 118602
- URL: https://www.wjgnet.com/2220-3249/full/v15/i1/118602.htm
- DOI: https://dx.doi.org/10.5501/wjv.v15.i1.118602